SLC5A2 and urinary tract infection: Following the line of data exposed in the previous subsection, we further evaluated the risk of contracting a urinary tract infection by determining the odds ratio for BMI, HbA1c, and the use of an SGLT2 inhibitor for the treatment of T2DM.